Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jitsuda Sitthi-amorn"'
Autor:
Chindo Hicks, Jitsuda Sitthi-Amorn, Jessica Douglas, Ritika Ramani, Lucio Miele, Vani Vijayakumar, Cynthia Karlson, James Chipeta, Gail Megason
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2016, Iss 10, Pp 5-15 (2016)
Externí odkaz:
https://doaj.org/article/59e1e927f5654519ac1095487961a7f2
Autor:
Jitsuda Sitthi-amorn, Betty Herrington, Gail Megason, Jeanette Pullen, Catherine Gordon, Shirley Hogan, Tejaswi Koganti, Chindo Hicks
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2015, Iss 9, Pp 51-60 (2015)
Externí odkaz:
https://doaj.org/article/d7ad303283e14b1d8ce525db57e674a8
Autor:
Chindo Hicks, Tejaswi Koganti, Shankar Giri, Memory Tekere, Ritika Ramani, Jitsuda Sitthi-Amorn, Srinivasan Vijayakumar
Publikováno v:
Biomarker Insights, Vol 2014, Iss 9, Pp 39-51 (2014)
Externí odkaz:
https://doaj.org/article/2ace7f27103448d6a3dd1a6599b95546
Autor:
Michael Terao, Claire L. Stokes, Jitsuda Sitthi‐Amorn, Anna Vinitsky, Jonathan D. Burlison, Justin N. Baker, Chen Li, Zhaohua Lu, Marian McDonald, James M. Hoffman
Publikováno v:
Pediatric Blood & Cancer. 69
Pediatric hematology/oncology fellows face unique quality improvement challenges given the danger of chemotherapy and caring for immunocompromised patients. Curricula to teach pediatric hematology/oncology fellows about quality improvement are lackin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1c68552f5c3c6cc4cdb611bc100c49
https://doi.org/10.1002/pbc.29794
https://doi.org/10.1002/pbc.29794
Autor:
Stacey Morgan, Allison Ast, Liza-Marie Johnson, Wendy Bourland, Brian Abbott, Erin Harper, Yaser Alsaek, David Wittman, Christopher Spencer, Rachael Courtney, Aditya Sharma, John McCormick, Arshia Madni, Lane McCurrach, Jitsuda Sitthi-Amorn
Publikováno v:
Pediatric Quality & Safety
Supplemental Digital Content is available in the text.
Introduction: Patients receiving cyclophosphamide or ifosfamide chemotherapy require intravenous fluid hydration to prevent hemorrhagic cystitis. In selected patients without medical contrai
Introduction: Patients receiving cyclophosphamide or ifosfamide chemotherapy require intravenous fluid hydration to prevent hemorrhagic cystitis. In selected patients without medical contrai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea81e163267b18b4afb96bd02a120c1
http://europepmc.org/articles/PMC8225375
http://europepmc.org/articles/PMC8225375
Outcomes and disposition of oncology patients with non-neutropenic fever and positive blood cultures
Autor:
Liza-Marie Johnson, Joshua Wolf, Aditya Sharma, Asya Agulnik, Jitsuda Sitthi-Amorn, Ying Li, Alex M. Brenner, Patrick Gavigan
Publikováno v:
J Pediatr Hematol Oncol
Children with cancer and non-neutropenic fever (NNF) episodes are often treated as outpatients if they appear well. However, a small subset have bloodstream infections (BSIs) and must return for further evaluation. These patients may be directly admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccbefea3a8af4e0b85d189ad8e80f90
https://europepmc.org/articles/PMC7762736/
https://europepmc.org/articles/PMC7762736/
Autor:
Jitsuda, Sitthi-Amorn, Emily, Denton, Erin, Harper, Delia, Carias, Saman, Hashmi, Sakshi, Bami, Allison, Ast, Taylor, Landry, Kenneth L, Pettit, Shilpa, Gorantla, Anna, Vinitsky, Yan, Zheng, Liza-Marie, Johnson
Publikováno v:
Pediatric Quality & Safety. 7:e572
Premedication with acetaminophen and/or diphenhydramine to prevent febrile nonhemolytic transfusion reactions and minor allergic transfusion reactions is a common practice based on historical recommendations. However, recent small randomized-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a27d0586cb501eb28f649f474fa6bc6
https://doi.org/10.1097/pq9.0000000000000572
https://doi.org/10.1097/pq9.0000000000000572
Autor:
Ritika Ramani, Jitsuda Sitthi-Amorn, Cynthia W. Karlson, Vani Vijayakumar, James Chipeta, Lucio Miele, Gail Megason, Chindo Hicks, Jessica Douglas
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 10 (2016)
Clinical Medicine Insights: Oncology, Vol 2016, Iss 10, Pp 5-15 (2016)
Clinical Medicine Insights: Oncology, Vol 10 (2016)
Clinical Medicine Insights: Oncology, Vol 2016, Iss 10, Pp 5-15 (2016)
Treatment of the central nervous system (CNS) is an essential therapeutic component in childhood acute lymphoblastic leukemia (ALL). The goal of this study was to identify molecular signatures distinguishing patients with CNS disease from those witho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d202f704f26d355a2ea58701a6e1a287
http://europepmc.org/articles/PMC4792199
http://europepmc.org/articles/PMC4792199
Publikováno v:
Pediatric Quality & Safety
Introduction Communication failures are common root causes of serious medical errors. Standardized, structured handoffs improve communication and patient safety. I-PASS is a handoff program that decreases medical errors and preventable patient harm.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85dbde09958c7e3cf7613ada7cfb4d9
https://doi.org/10.1097/pq9.0000000000000323
https://doi.org/10.1097/pq9.0000000000000323
Autor:
Shirley Hogan, Jitsuda Sitthi-Amorn, Betty Herrington, Jeanette Pullen, Catherine M. Gordon, Tejaswi Koganti, Gail Megason, Chindo Hicks
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2015, Iss 9, Pp 51-60 (2015)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 9 (2015)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 9 (2015)
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and the leading cause of cancer-related death in children and adolescents. Minimal residual disease (MRD) is a strong, independent prognostic factor. The objective of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf60eb4f53098f1c20c555bba1de9f0
https://doi.org/10.4137/cmo.s17049
https://doi.org/10.4137/cmo.s17049